Cencora, Inc.
Close on Nov 20, 2026Market cap $64.71BP/E 25.2Yield 0.65%
Cencora Peer Benchmark: Cardinal Health, Inc. (CAH) by Quarter
Peer Benchmark: Cardinal Health, Inc. (CAH) — Consolidated Revenue ($M) ($M)
Cencora Peer Benchmark: Cardinal Health, Inc. (CAH): $65,627M in Q1 FY26, up 18.8% from a year earlier. That is the highest of the 64 quarters on record here.
Where the Q1 FY26 figure comes from
“CAH us-gaap:Revenues = $65,627,000,000 (2025-10-01 to 2025-12-31)”
Source: SEC EDGAR XBRL CompanyFacts (CAH) ↗
SEC XBRL quarterly and annual financial benchmark for Big-3 pharmaceutical distribution peer Cardinal Health, Inc. (CIK 0000721371, aligned to Cencora's fiscal calendar).
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Peer Benchmark: Cardinal Health, Inc. (CAH) — Consolidated Revenue ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q1 FY26CQ4 2025 | Dec 31, 2025 | 65,627 | +18.8% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q4 FY25CQ3 2025 | Sep 30, 2025 | 64,009 | +22.4% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q2 FY25CQ1 2025 | Mar 31, 2025 | 54,878 | 0.0% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q1 FY25CQ4 2024 | Dec 31, 2024 | 55,264 | -3.8% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q4 FY24CQ3 2024 | Sep 30, 2024 | 52,277 | -4.3% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q2 FY24CQ1 2024 | Mar 31, 2024 | 54,868 | +8.7% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q1 FY24CQ4 2023 | Dec 31, 2023 | 57,442 | +11.6% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q4 FY23CQ3 2023 | Sep 30, 2023 | 54,650 | +10.2% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q2 FY23CQ1 2023 | Mar 31, 2023 | 50,498 | +12.6% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q1 FY23CQ4 2022 | Dec 31, 2022 | 51,468 | +13.2% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q4 FY22CQ3 2022 | Sep 30, 2022 | 49,592 | +12.8% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q2 FY22CQ1 2022 | Mar 31, 2022 | 44,836 | +14.2% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q1 FY22CQ4 2021 | Dec 31, 2021 | 45,457 | +9.4% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q4 FY21CQ3 2021 | Sep 30, 2021 | 43,968 | +12.6% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q2 FY21CQ1 2021 | Mar 31, 2021 | 39,275 | +0.3% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q1 FY21CQ4 2020 | Dec 31, 2020 | 41,541 | +4.5% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q4 FY20CQ3 2020 | Sep 30, 2020 | 39,065 | +4.6% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q3 FY20CQ2 2020 | Jun 30, 2020 | 36,689 | -1.8% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q2 FY20CQ1 2020 | Mar 31, 2020 | 39,157 | +11.2% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q1 FY20CQ4 2019 | Dec 31, 2019 | 39,735 | +5.3% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q4 FY19CQ3 2019 | Sep 30, 2019 | 37,341 | +6.0% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q3 FY19CQ2 2019 | Jun 30, 2019 | 37,353 | +5.7% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q2 FY19CQ1 2019 | Mar 31, 2019 | 35,228 | +4.7% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q1 FY19CQ4 2018 | Dec 31, 2018 | 37,740 | +7.3% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q4 FY18CQ3 2018 | Sep 30, 2018 | 35,213 | +7.9% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q3 FY18CQ2 2018 | Jun 30, 2018 | 35,349 | +7.2% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q2 FY18CQ1 2018 | Mar 31, 2018 | 33,633 | +5.7% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q1 FY18CQ4 2017 | Dec 31, 2017 | 35,186 | +6.1% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q4 FY17CQ3 2017 | Sep 30, 2017 | 32,641 | +1.9% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q3 FY17CQ2 2017 | Jun 30, 2017 | 32,966 | +5.0% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q2 FY17CQ1 2017 | Mar 31, 2017 | 31,821 | +3.8% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q1 FY17CQ4 2016 | Dec 31, 2016 | 33,150 | +5.4% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q4 FY16CQ3 2016 | Sep 30, 2016 | 32,039 | +14.2% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q3 FY16CQ2 2016 | Jun 30, 2016 | 31,384 | +13.9% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q2 FY16CQ1 2016 | Mar 31, 2016 | 30,662 | +20.8% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q1 FY16CQ4 2015 | Dec 31, 2015 | 31,445 | +23.1% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q4 FY15CQ3 2015 | Sep 30, 2015 | 28,055 | +16.6% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q3 FY15CQ2 2015 | Jun 30, 2015 | 27,547 | +20.3% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q2 FY15CQ1 2015 | Mar 31, 2015 | 25,375 | +18.4% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q1 FY15CQ4 2014 | Dec 31, 2014 | 25,537 | +14.8% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q4 FY14CQ3 2014 | Sep 30, 2014 | 24,070 | -1.8% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q3 FY14CQ2 2014 | Jun 30, 2014 | 22,894 | -9.9% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q2 FY14CQ1 2014 | Mar 31, 2014 | 21,427 | -12.7% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q1 FY14CQ4 2013 | Dec 31, 2013 | 22,240 | -11.9% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q4 FY13CQ3 2013 | Sep 30, 2013 | 24,523 | -5.3% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q3 FY13CQ2 2013 | Jun 30, 2013 | 25,420 | -5.0% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q2 FY13CQ1 2013 | Mar 31, 2013 | 24,552 | -8.8% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q1 FY13CQ4 2012 | Dec 31, 2012 | 25,232 | -6.8% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q4 FY12CQ3 2012 | Sep 30, 2012 | 25,889 | -3.4% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q3 FY12CQ2 2012 | Jun 30, 2012 | 26,764 | 0.0% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q2 FY12CQ1 2012 | Mar 31, 2012 | 26,918 | +3.2% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q1 FY12CQ4 2011 | Dec 31, 2011 | 27,078 | +6.7% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q4 FY11CQ3 2011 | Sep 30, 2011 | 26,792 | +9.6% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q3 FY11CQ2 2011 | Jun 30, 2011 | 26,764 | +9.4% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q2 FY11CQ1 2011 | Mar 31, 2011 | 26,071 | +7.1% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q1 FY11CQ4 2010 | Dec 31, 2010 | 25,372 | +1.8% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q4 FY10CQ3 2010 | Sep 30, 2010 | 24,438 | -1.4% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q3 FY10CQ2 2010 | Jun 30, 2010 | 24,460 | – | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q2 FY10CQ1 2010 | Mar 31, 2010 | 24,343 | +1.1% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q1 FY10CQ4 2009 | Dec 31, 2009 | 24,920 | +3.3% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q4 FY09CQ3 2009 | Sep 30, 2009 | 24,781 | +5.7% | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q2 FY09CQ1 2009 | Mar 31, 2009 | 24,089 | – | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q1 FY09CQ4 2008 | Dec 31, 2008 | 24,118 | – | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
| Q4 FY08CQ3 2008 | Sep 30, 2008 | 23,437 | – | SEC EDGAR XBRL CompanyFacts (CAH) ↗ |
Breakdown
What makes up peer Benchmark: Cardinal Health, Inc. (CAH)
Cite this data
StockData. (2026). Cencora Peer Benchmark: Cardinal Health, Inc. (CAH) ($M), quarterly Q4 FY08–Q1 FY26 [Data set]. Compiled from Cencora SEC filings and investor materials. https://stockdatahq.com/stocks/cor/kpis/peer-cah-rev
See every metric in the Cencora KPI table. Data updated Nov 7, 2026.
See a number that looks wrong?